CIK 0001846253
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-28 | FOEHR MATTHEW W President & CEO | Shares withheld for taxes | −11,624 | $3.66 | $43K | 1,826,460 |
| 2022-12-12 | FOEHR MATTHEW W President & CEO | Purchase | +150,000 | $3.77 | $565K | 1,838,084 |
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other disposition | −15,817,934 | 0 | ||
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other acquisition | +7,283,484 | 7,283,484 | ||
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other acquisition | +8,534,450 | 8,534,450 | ||
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other disposition · Warrants | −11,345,489 | 0 | ||
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other acquisition · Warrants | +5,224,114 | 5,224,114 | ||
| 2022-12-09 | Avista Acquisition GP LLC II Director | Other acquisition · Warrants | +6,121,375 | 6,121,375 | ||
| 2022-12-07 | GUSTAFSON KURT A EVP, Finance and CFO | Grant or award · Stock Option | +697,520 | 697,520 | ||
| 2022-12-07 | FOEHR MATTHEW W President & CEO | Grant or award · Stock Option | +298,311 | 298,311 | ||
| 2022-12-07 | Berkman Charles S See Remarks | Grant or award · Stock Option | +175,477 | 175,477 | ||
| 2022-12-06 | Cochran Jennifer R. Director | Purchase | +22,250 | $3.75 | $84K | 77,476 |
| 2022-12-01 | Bertozzi Carolyn R Director | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2022-12-01 | Berkman Charles S See Remarks | Shares withheld for taxes | −10,580 | $3.35 | $35K | 343,136 |
| 2022-12-01 | GUSTAFSON KURT A EVP, Finance and CFO | Shares withheld for taxes | −6,733 | $3.35 | $23K | 163,329 |
| 2022-12-01 | Avista Acquisition GP LLC II Director | Grant or award · Stock Option | +161,849 | 161,849 | ||
| 2022-12-01 | FOEHR MATTHEW W President & CEO | Shares withheld for taxes | −17,266 | $3.35 | $58K | 1,688,084 |
| 2022-12-01 | Bertozzi Carolyn R Director | Grant or award · Stock Option | +161,849 | 161,849 | ||
| 2022-11-30 | FOEHR MATTHEW W President & CEO | Purchase | +300,000 | $3.39 | $1.0M | 1,705,350 |
| 2022-11-28 | GUSTAFSON KURT A EVP, Finance and CFO | Purchase | +10,000 | $2.81 | $28K | 170,062 |
Page 17 of 21 · 404 trades